SWISS NATIONAL BANK – Regeneron Pharmaceuticals, Inc. Transaction History
SWISS NATIONAL BANK portfolio value:
$322.51M
portfolio value
SWISS NATIONAL BANK quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.15% | 5.3K shares | 48.89M | $688.87 | 468.17K |
| Q2 2022 | share | Increase | +1.09% | 5K shares | -46.16M | $591.13 | 462.87K |
| Q1 2022 | share | Increase | +14.62% | 58.4K shares | 67.51M | $698.42 | 457.87K |
| Q4 2021 | share | Decrease | -3.50% | -14.5K shares | 1.74M | $642.51 | 399.47K |
| Q3 2021 | share | Decrease | -3.59% | -15.4K shares | 10.70M | $605.18 | 413.97K |
| Q2 2021 | share | Decrease | -29.24% | -177.45K shares | -47.29M | $558.54 | 429.37K |
| Q1 2021 | share | Increase | +1.79% | 10.7K shares | -880K | $473.14 | 606.82K |
| Q4 2020 | share | Increase | +4.56% | 26K shares | -31.15M | $483.11 | 596.12K |
| Q3 2020 | share | Increase | +18.87% | 90.5K shares | 20.02M | $559.78 | 570.12K |
| Q2 2020 | share | Increase | +52.64% | 165.4K shares | 145.68M | $623.65 | 479.62K |
| Q1 2020 | share | Increase | +23.02% | 58.8K shares | 57.52M | $488.29 | 314.22K |
| Q4 2019 | share | Decrease | -4.27% | -11.4K shares | 21.89M | $375.48 | 255.42K |
| Q3 2019 | share | Increase | +1.69% | 4.42K shares | -8.11M | $277.4 | 266.82K |
| Q2 2019 | share | Decrease | -1.43% | -3.8K shares | -27.17M | $313 | 262.4K |
| Q1 2019 | share | Increase | +2.86% | 7.4K shares | 12.64M | $410.62 | 266.2K |
| Q4 2018 | share | Increase | +2.01% | 5.1K shares | -5.84M | $373.5 | 258.8K |
| Q3 2018 | share | Decrease | -3.09% | -8.1K shares | 12.18M | $404.04 | 253.7K |
| Q2 2018 | share | Increase | +3.11% | 7.9K shares | 2.88M | $344.99 | 261.8K |
| Q1 2018 | share | Decrease | -12.11% | -35K shares | -21.18M | $344.36 | 253.9K |
| Q4 2017 | share | Increase | +0.14% | 400 shares | -20.37M | $375.96 | 288.9K |
| Q3 2017 | share | Increase | +1.09% | 3.1K shares | -11.17M | $447.12 | 288.5K |
| Q2 2017 | share | Increase | +3.67% | 10.1K shares | 33.48M | $491.14 | 285.4K |
| Q1 2017 | share | Increase | +27.45% | 59.3K shares | 27.39M | $387.51 | 275.3K |
| Q4 2016 | share | Increase | +0.79% | 1.7K shares | -6.86M | $367.09 | 216K |
| Q3 2016 | share | Decrease | -0.97% | -2.1K shares | 10.58M | $402.02 | 214.3K |
| Q2 2016 | share | Increase | +8.69% | 17.3K shares | 6.79M | $349.23 | 216.4K |
| Q1 2016 | share | Increase | +43.75% | 60.6K shares | -6.40M | $360.44 | 199.1K |